Recombinant Human TNFSF14/LIGHT Protein (His Tag) - PKSH031639Recombinant Human TNFSF14 LIGHT Protein (His Tag) Size: 100g Catalogue Number: PKSH031639 100 Citations, Manuals and MSDS Available upon request. Abbreviation: TNFSF14; LIGHT Target Symptom: CD258; HVEML; LIGHT; LTg; TR2; Tumor necrosis factor ligand superfamily member 14; Herpes virus entry mediator ligand; TNFSF14; HVEM L; LIGHT Research Area: immunology Target Species: Human Expression Host: HEK293 Cells Fusion Tag: N His Accession: NP_003798. 2
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Recombinant Human TNFSF14/LIGHT Protein (His Tag)
Size: 100μg
Catalogue Number: PKSH031639-100
Citations, Manuals and MSDS Available upon request.
Abbreviation: TNFSF14; LIGHT
Target Symptom: CD258; HVEML; LIGHT; LTg; TR2; Tumor necrosis factor ligand superfamily member 14; Herpes virus entry mediator ligand; TNFSF14; HVEM-L; LIGHT
Research Area: immunology
Target Species: Human
Expression Host: HEK293 Cells
Fusion Tag: N-His
Accession: NP_003798.2
Background: LIGHT, also known as TNFSF14 or CD258, is a newly identified member of the TNF superfamily (TNFSF14) that is expressed by activated T lymphocytes, monocytes, granulocytes, spleen cells, and immature dendritic cells. TNFSF14 / LIGHT / CD258 is a type II transmembrane protein that is known to bind 2 membrane-bound TNFSF signaling receptors: HVEM, which is predominantly expressed by T cells, and lymphotoxin β receptor (LTβ R), which is expressed by stromal cells and nonlymphoid hematopoietic cells. TNFSF14 / LIGHT / CD258 also binds to a soluble nonsignaling receptor, decoy receptor 3 (DcR3), which can modulate the function of LIGHT in vivo. TNFSF14 / LIGHT / CD258 can also costimulate T cell responses via HVEM, which is constitutively expressed in most lymphocyte subpopulations, including CD4+ and CD8+ T cells. In addition, TNFSF14 / LIGHT / CD258 has been shown to suppress tumor formation in vivo and to induce tumor cell apoptosis via the up-regulation of intercellular adhesion molecule 1 and an increased lymphocyte adhesion to cancer cells. Thus, TNFSF14 / LIGHT / CD258 is being actively investigated as a possible basis for cancer treatment.
Sequence: Asp 74-Val 240
Purity: > 85 % as determined by reducing SDS-PAGE.
Formulation: Lyophilized from sterile PBS, pH 7.4
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution: Please refer to the printed manual for detailed information.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 20.4 kDa
Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Research Use Only
Show More
Recombinant Human TNFSF14/LIGHT Protein (His Tag) - PKSH031639